ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $36,000 | -73.1% | 2,325 | -61.1% | 0.02% | -60.5% |
| Q1 2018 | $134,000 | -22.1% | 5,977 | +4.4% | 0.04% | -24.0% |
| Q4 2017 | $172,000 | +3.0% | 5,727 | +29.4% | 0.05% | -10.7% |
| Q3 2017 | $167,000 | +33.6% | 4,427 | -1.2% | 0.06% | +24.4% |
| Q2 2017 | $125,000 | +81.2% | 4,479 | +60.5% | 0.04% | +28.6% |
| Q3 2014 | $69,000 | +72.5% | 2,790 | +59.4% | 0.04% | +84.2% |
| Q2 2014 | $40,000 | +471.4% | 1,750 | +483.3% | 0.02% | +850.0% |
| Q1 2014 | $7,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $7,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |